How many institutions held PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share in Q1 2022?

44 institutional investors reported PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share for Q1 2022. Use the holders table for investor-level position and value details.

Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS)

Q: What does CUSIP 747324101 represent in this 13F holders report?

CUSIP 747324101 is the security identifier for PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 747324101

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 62,130,557
Total 13F shares: 18,945,997
Share change: +605,826
Total reported value: $76,067,000
Price per share: $4.04
Number of holders: 44
Value change: -$5,559,229
Number of buys: 17
Number of sells: 25

Quarterly Holders Quick Answers

What is CUSIP 747324101?
CUSIP 747324101 identifies PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2022
Previous quarter: Q4 2021

Recent filing periods for CUSIP 747324101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RA CAPITAL MANAGEMENT, L.P.	13F	Company	3.7%	2,282,173	$25,035,000	—	31 Dec 2021	13F
RTW INVESTMENTS, LP	13F	Company	3.4%	2,120,760	$23,265,000	—	31 Dec 2021	13F
PERCEPTIVE ADVISORS LLC	13F	Company	3.1%	1,944,114	$21,326,000	—	31 Dec 2021	13F
BVF INC/IL	13F	Company	2.9%	1,791,351	$19,651,000	—	31 Dec 2021	13F
CITADEL ADVISORS LLC	13F	Company	2.4%	1,521,617	$16,482,000	—	31 Dec 2021	13F
JANUS HENDERSON GROUP PLC	13F	Company	2.4%	1,469,091	$15,277,000	—	31 Dec 2021	13F
Laurion Capital Management LP	13F	Company	1.9%	1,162,332	$12,751,000	—	31 Dec 2021	13F
HHLR ADVISORS, LTD.	13F	Company	1.2%	764,406	$8,386,000	—	31 Dec 2021	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	1.1%	677,753	$7,435,000	—	31 Dec 2021	13F
Cormorant Asset Management, LP	13F 3/4/5	Company · Former 10% Owner	1.1%	668,854	$7,117,000	—	31 Dec 2021	13F 3/4/5
VANGUARD GROUP INC	13F	Company	0.84%	520,298	$5,707,000	—	31 Dec 2021	13F
BlackRock Finance, Inc.	13F	Company	0.83%	513,848	$5,637,000	—	31 Dec 2021	13F
GREAT POINT PARTNERS LLC	13F	Company	0.64%	400,000	$4,388,000	—	31 Dec 2021	13F
Bayer World Investments B.V.	3/4/5	Former 10% Owner	— class O/S missing	2,742,338	$3,839,273	—	13 Oct 2021	3/4/5
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.5%	311,754	$3,420,000	—	31 Dec 2021	13F
Ghost Tree Capital, LLC	13F	Company	0.47%	295,000	$3,236,000	—	31 Dec 2021	13F
Logos Global Management LP	13F	Company	0.46%	286,652	$3,144,000	—	31 Dec 2021	13F
ExodusPoint Capital Management, LP	13F	Company	0.4%	249,762	$2,740,000	—	31 Dec 2021	13F
HealthCor Management, L.P.	13F	Company	0.39%	244,838	$2,686,000	—	31 Dec 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.29%	181,472	$1,990,000	—	31 Dec 2021	13F
ORBIMED ADVISORS LLC	13F	Company	0.23%	143,640	$1,576,000	—	31 Dec 2021	13F
Tekla Capital Management LLC	13F	Company	0.22%	135,000	$1,481,000	—	31 Dec 2021	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.18%	112,762	$1,237,000	—	31 Dec 2021	13F
STATE STREET CORP	13F	Company	0.15%	92,875	$1,019,000	—	31 Dec 2021	13F
NORTHERN TRUST CORP	13F	Company	0.14%	89,235	$979,000	—	31 Dec 2021	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	0.08%	50,000	$549,000	—	31 Dec 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.05%	31,461	$345,000	—	31 Dec 2021	13F
Squarepoint Ops LLC	13F	Company	0.05%	31,328	$344,000	—	31 Dec 2021	13F
Ghisallo Capital Management LLC	13F	Company	0.05%	30,000	$329,000	—	31 Dec 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.05%	28,616	$314,000	—	31 Dec 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.04%	23,094	$254,000	—	31 Dec 2021	13F
Ronald Herbst	3/4/5	Chief Scientific Officer	— mixed-class rows	118,674 mixed-class rows	$234,796	—	07 Oct 2021	3/4/5
Bank of New York Mellon Corp	13F	Company	0.03%	19,284	$212,000	—	31 Dec 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.03%	16,163	$177,000	—	31 Dec 2021	13F
Walleye Capital LLC	13F	Company	0.03%	15,933	$175,000	—	31 Dec 2021	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	0.02%	13,624	$149,000	—	31 Dec 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.02%	11,769	$129,000	—	31 Dec 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.02%	11,414	$125,000	—	31 Dec 2021	13F
Ritu Shah	3/4/5	Chief Operating Officer	— class O/S missing	31,344	$120,048	—	07 Oct 2021	3/4/5
D. E. Shaw & Co., Inc.	13F	Company	0.02%	10,367	$114,000	—	31 Dec 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.02%	10,253	$112,000	—	31 Dec 2021	13F
Sandia Investment Management LP	13F	Company	0.02%	10,000	$110,000	—	31 Dec 2021	13F
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP	13F	Company	0.02%	10,000	$109,000	—	31 Dec 2021	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	6,277	$69,000	—	31 Dec 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	5,856	$64,000	—	31 Dec 2021	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	5,650	$62,000	—	31 Dec 2021	13F
UBS Group AG	13F	Company	0.01%	4,818	$53,000	—	31 Dec 2021	13F
CITIGROUP INC	13F	Company	0.01%	3,206	$35,000	—	31 Dec 2021	13F
MORGAN STANLEY	13F	Company	0%	2,832	$31,000	—	31 Dec 2021	13F
STRS OHIO	13F	Company	0%	2,500	$27,000	—	31 Dec 2021	13F

Institutional Holders of Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) as of Q1 2022

As of 31 Mar 2022, Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,945,997 shares. The largest 10 holders included BVF INC/IL, RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP, PERCEPTIVE ADVISORS LLC, CITADEL ADVISORS LLC, JANUS HENDERSON GROUP PLC, Laurion Capital Management LP, BARCLAYS PLC, HHLR ADVISORS, LTD., and Tekla Capital Management LLC. This page lists 44 institutional shareholders reporting positions in this security for the Q1 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders

Q1 2022 holders

Holder diff

-7

Investor	Q4 2021 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q4 2021 Value $	Q1 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.